CONMED Corporation
CNMD
$58.29
-$0.6278-1.07%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 105.44% | 127.25% | 11.68% | 187.85% | 179.99% |
| Total Depreciation and Amortization | 0.40% | 0.93% | 1.14% | 2.56% | 4.09% |
| Total Amortization of Deferred Charges | -8.48% | -8.67% | -6.75% | 0.30% | 10.67% |
| Total Other Non-Cash Items | -114.59% | -62.15% | 117.63% | -88.80% | -82.69% |
| Change in Net Operating Assets | -0.37% | 84.71% | 88.27% | 80.59% | 56.36% |
| Cash from Operations | 33.20% | 213.88% | 371.29% | 442.36% | 275.69% |
| Capital Expenditure | 31.25% | 29.99% | 25.02% | 24.78% | 12.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | 100.00% | -- | -- |
| Cash from Investing | 34.68% | 35.34% | 85.21% | 92.88% | 91.97% |
| Total Debt Issued | 8.53% | 19.24% | 32.31% | -41.57% | -45.08% |
| Total Debt Repaid | -5.51% | -24.93% | -59.47% | 11.04% | 13.14% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.61% | -0.72% | -0.86% | -1.54% | -2.26% |
| Other Financing Activities | -2,725.56% | -479.64% | -451.89% | 76.51% | 101.83% |
| Cash from Financing | -36.74% | -295.25% | -457.41% | -159.59% | -149.08% |
| Foreign Exchange rate Adjustments | -678.94% | -62.82% | -197.86% | -6.46% | 163.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.51% | 379.28% | 104.03% | 351.60% | -157.39% |
